TrialThe oncologist2010

A phase II study of pazopanib in patients with recurrent or metastatic invasive breast carcinoma: a trial of the Princess Margaret Hospital phase II consortium.

Sara K Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.